Stocks
MyMD Pharmaceuticals IncMYMD
HealthcareBiotechnology
A clinical-stage biopharmaceutical company developing therapies for age-related diseases, including sarcopenia and frailty, with a focus on its lead candidate MYMD-1. The company is also advancing treatments for autoimmune and inflammatory conditions. Investors track it for its pipeline progress and regulatory milestones.
Congressional Interest in MyMD Pharmaceuticals Inc (MYMD)
1 member of Congress has disclosed 1 trade in MyMD Pharmaceuticals Inc (MYMD), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading MYMD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-10-07 | KENNY MARCHANT | buy | $1K-$15K |